nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—SLC22A2—Vinblastine—head and neck cancer	0.529	1	CbGbCtD
Famotidine—Bone marrow depression—Hydroxyurea—head and neck cancer	0.0132	0.0281	CcSEcCtD
Famotidine—Extravasation—Vinblastine—head and neck cancer	0.0112	0.0238	CcSEcCtD
Famotidine—Interstitial pneumonia—Docetaxel—head and neck cancer	0.00961	0.0204	CcSEcCtD
Famotidine—Extravasation—Fluorouracil—head and neck cancer	0.00737	0.0157	CcSEcCtD
Famotidine—Disorientation—Hydroxyurea—head and neck cancer	0.00725	0.0154	CcSEcCtD
Famotidine—Interstitial lung disease—Docetaxel—head and neck cancer	0.00656	0.0139	CcSEcCtD
Famotidine—Face oedema—Hydroxyurea—head and neck cancer	0.00626	0.0133	CcSEcCtD
Famotidine—Pancytopenia—Vinblastine—head and neck cancer	0.00584	0.0124	CcSEcCtD
Famotidine—Depression—Vinblastine—head and neck cancer	0.00547	0.0116	CcSEcCtD
Famotidine—Pancytopenia—Hydroxyurea—head and neck cancer	0.00532	0.0113	CcSEcCtD
Famotidine—Extravasation—Docetaxel—head and neck cancer	0.00532	0.0113	CcSEcCtD
Famotidine—Photosensitivity—Fluorouracil—head and neck cancer	0.00532	0.0113	CcSEcCtD
Famotidine—Swelling—Fluorouracil—head and neck cancer	0.00529	0.0112	CcSEcCtD
Famotidine—Neutropenia—Hydroxyurea—head and neck cancer	0.00524	0.0111	CcSEcCtD
Famotidine—Dysuria—Hydroxyurea—head and neck cancer	0.00524	0.0111	CcSEcCtD
Famotidine—Disorientation—Fluorouracil—head and neck cancer	0.00522	0.0111	CcSEcCtD
Famotidine—Agranulocytosis—Vinblastine—head and neck cancer	0.00511	0.0109	CcSEcCtD
Famotidine—Pharyngitis—Vinblastine—head and neck cancer	0.00488	0.0104	CcSEcCtD
Famotidine—Influenza like illness—Docetaxel—head and neck cancer	0.00451	0.00957	CcSEcCtD
Famotidine—Hallucination—Hydroxyurea—head and neck cancer	0.00446	0.00948	CcSEcCtD
Famotidine—Irritability—Fluorouracil—head and neck cancer	0.00446	0.00946	CcSEcCtD
Famotidine—Alopecia—Vinblastine—head and neck cancer	0.00435	0.00923	CcSEcCtD
Famotidine—Dry skin—Fluorouracil—head and neck cancer	0.00428	0.00909	CcSEcCtD
Famotidine—Alopecia—Hydroxyurea—head and neck cancer	0.00397	0.00842	CcSEcCtD
Famotidine—Anaemia—Vinblastine—head and neck cancer	0.00396	0.00841	CcSEcCtD
Famotidine—Leukopenia—Vinblastine—head and neck cancer	0.00383	0.00814	CcSEcCtD
Famotidine—Pancytopenia—Fluorouracil—head and neck cancer	0.00383	0.00814	CcSEcCtD
Famotidine—Swelling—Docetaxel—head and neck cancer	0.00382	0.00811	CcSEcCtD
Famotidine—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00375	0.00796	CcSEcCtD
Famotidine—Convulsion—Vinblastine—head and neck cancer	0.00371	0.00788	CcSEcCtD
Famotidine—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00368	0.00782	CcSEcCtD
Famotidine—Anaemia—Hydroxyurea—head and neck cancer	0.00361	0.00767	CcSEcCtD
Famotidine—Leukopenia—Hydroxyurea—head and neck cancer	0.0035	0.00742	CcSEcCtD
Famotidine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00342	0.00727	CcSEcCtD
Famotidine—Convulsion—Hydroxyurea—head and neck cancer	0.00338	0.00719	CcSEcCtD
Famotidine—Sinusitis—Fluorouracil—head and neck cancer	0.00338	0.00717	CcSEcCtD
Famotidine—Pain in extremity—Docetaxel—head and neck cancer	0.00337	0.00716	CcSEcCtD
Famotidine—Agranulocytosis—Fluorouracil—head and neck cancer	0.00336	0.00713	CcSEcCtD
Famotidine—Anorexia—Vinblastine—head and neck cancer	0.00333	0.00708	CcSEcCtD
Famotidine—Migraine—Docetaxel—head and neck cancer	0.00332	0.00704	CcSEcCtD
Famotidine—Pharyngitis—Fluorouracil—head and neck cancer	0.00321	0.00681	CcSEcCtD
Famotidine—Oedema—Hydroxyurea—head and neck cancer	0.00319	0.00677	CcSEcCtD
Famotidine—Infection—Hydroxyurea—head and neck cancer	0.00317	0.00673	CcSEcCtD
Famotidine—Paraesthesia—Vinblastine—head and neck cancer	0.00314	0.00667	CcSEcCtD
Famotidine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00312	0.00663	CcSEcCtD
Famotidine—Dry skin—Docetaxel—head and neck cancer	0.00309	0.00656	CcSEcCtD
Famotidine—Anorexia—Hydroxyurea—head and neck cancer	0.00304	0.00645	CcSEcCtD
Famotidine—Decreased appetite—Vinblastine—head and neck cancer	0.00304	0.00645	CcSEcCtD
Famotidine—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00303	0.00644	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00303	0.00644	CcSEcCtD
Famotidine—Cramp muscle—Docetaxel—head and neck cancer	0.00303	0.00644	CcSEcCtD
Famotidine—Constipation—Vinblastine—head and neck cancer	0.00299	0.00635	CcSEcCtD
Famotidine—Pain—Vinblastine—head and neck cancer	0.00299	0.00635	CcSEcCtD
Famotidine—Arrhythmia—Fluorouracil—head and neck cancer	0.00289	0.00613	CcSEcCtD
Famotidine—Feeling abnormal—Vinblastine—head and neck cancer	0.00288	0.00612	CcSEcCtD
Famotidine—Bronchospasm—Docetaxel—head and neck cancer	0.00286	0.00608	CcSEcCtD
Famotidine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00286	0.00607	CcSEcCtD
Famotidine—Alopecia—Fluorouracil—head and neck cancer	0.00285	0.00606	CcSEcCtD
Famotidine—Somnolence—Hydroxyurea—head and neck cancer	0.00283	0.00602	CcSEcCtD
Famotidine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00281	0.00596	CcSEcCtD
Famotidine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00277	0.00588	CcSEcCtD
Famotidine—Pancytopenia—Docetaxel—head and neck cancer	0.00277	0.00587	CcSEcCtD
Famotidine—Abdominal pain—Vinblastine—head and neck cancer	0.00276	0.00587	CcSEcCtD
Famotidine—Fatigue—Hydroxyurea—head and neck cancer	0.00275	0.00584	CcSEcCtD
Famotidine—Constipation—Hydroxyurea—head and neck cancer	0.00273	0.00579	CcSEcCtD
Famotidine—Pain—Hydroxyurea—head and neck cancer	0.00273	0.00579	CcSEcCtD
Famotidine—Neutropenia—Docetaxel—head and neck cancer	0.00272	0.00578	CcSEcCtD
Famotidine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00263	0.00558	CcSEcCtD
Famotidine—Anaemia—Fluorouracil—head and neck cancer	0.0026	0.00552	CcSEcCtD
Famotidine—Hypersensitivity—Vinblastine—head and neck cancer	0.00258	0.00547	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00257	0.00547	CcSEcCtD
Famotidine—Jaundice—Docetaxel—head and neck cancer	0.00253	0.00538	CcSEcCtD
Famotidine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00252	0.00535	CcSEcCtD
Famotidine—Leukopenia—Fluorouracil—head and neck cancer	0.00252	0.00534	CcSEcCtD
Famotidine—Asthenia—Vinblastine—head and neck cancer	0.00251	0.00533	CcSEcCtD
Famotidine—Convulsion—Fluorouracil—head and neck cancer	0.00244	0.00517	CcSEcCtD
Famotidine—Agranulocytosis—Docetaxel—head and neck cancer	0.00242	0.00515	CcSEcCtD
Famotidine—Myalgia—Fluorouracil—head and neck cancer	0.00239	0.00508	CcSEcCtD
Famotidine—Chest pain—Fluorouracil—head and neck cancer	0.00239	0.00508	CcSEcCtD
Famotidine—Diarrhoea—Vinblastine—head and neck cancer	0.00239	0.00508	CcSEcCtD
Famotidine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00235	0.00499	CcSEcCtD
Famotidine—Hepatitis—Docetaxel—head and neck cancer	0.00233	0.00495	CcSEcCtD
Famotidine—Confusional state—Fluorouracil—head and neck cancer	0.00231	0.00491	CcSEcCtD
Famotidine—Pharyngitis—Docetaxel—head and neck cancer	0.00231	0.00491	CcSEcCtD
Famotidine—Dizziness—Vinblastine—head and neck cancer	0.00231	0.00491	CcSEcCtD
Famotidine—Oedema—Fluorouracil—head and neck cancer	0.00229	0.00487	CcSEcCtD
Famotidine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00229	0.00487	CcSEcCtD
Famotidine—Asthenia—Hydroxyurea—head and neck cancer	0.00229	0.00486	CcSEcCtD
Famotidine—Infection—Fluorouracil—head and neck cancer	0.00228	0.00484	CcSEcCtD
Famotidine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00225	0.00477	CcSEcCtD
Famotidine—Vomiting—Vinblastine—head and neck cancer	0.00222	0.00472	CcSEcCtD
Famotidine—Erythema multiforme—Docetaxel—head and neck cancer	0.0022	0.00468	CcSEcCtD
Famotidine—Headache—Vinblastine—head and neck cancer	0.00219	0.00465	CcSEcCtD
Famotidine—Anorexia—Fluorouracil—head and neck cancer	0.00219	0.00464	CcSEcCtD
Famotidine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00218	0.00463	CcSEcCtD
Famotidine—Flushing—Docetaxel—head and neck cancer	0.00216	0.00459	CcSEcCtD
Famotidine—Dizziness—Hydroxyurea—head and neck cancer	0.00211	0.00448	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00209	0.00444	CcSEcCtD
Famotidine—Arrhythmia—Docetaxel—head and neck cancer	0.00208	0.00442	CcSEcCtD
Famotidine—Nausea—Vinblastine—head and neck cancer	0.00208	0.00441	CcSEcCtD
Famotidine—Insomnia—Fluorouracil—head and neck cancer	0.00208	0.00441	CcSEcCtD
Famotidine—Paraesthesia—Fluorouracil—head and neck cancer	0.00206	0.00438	CcSEcCtD
Famotidine—Alopecia—Docetaxel—head and neck cancer	0.00206	0.00437	CcSEcCtD
Famotidine—Mental disorder—Docetaxel—head and neck cancer	0.00204	0.00434	CcSEcCtD
Famotidine—Somnolence—Fluorouracil—head and neck cancer	0.00204	0.00433	CcSEcCtD
Famotidine—Vomiting—Hydroxyurea—head and neck cancer	0.00203	0.0043	CcSEcCtD
Famotidine—Dyspepsia—Fluorouracil—head and neck cancer	0.00202	0.00429	CcSEcCtD
Famotidine—Rash—Hydroxyurea—head and neck cancer	0.00201	0.00427	CcSEcCtD
Famotidine—Dermatitis—Hydroxyurea—head and neck cancer	0.00201	0.00426	CcSEcCtD
Famotidine—Headache—Hydroxyurea—head and neck cancer	0.002	0.00424	CcSEcCtD
Famotidine—Decreased appetite—Fluorouracil—head and neck cancer	0.00199	0.00424	CcSEcCtD
Famotidine—Dysgeusia—Docetaxel—head and neck cancer	0.00199	0.00422	CcSEcCtD
Famotidine—Back pain—Docetaxel—head and neck cancer	0.00196	0.00417	CcSEcCtD
Famotidine—Pain—Fluorouracil—head and neck cancer	0.00196	0.00417	CcSEcCtD
Famotidine—Muscle spasms—Docetaxel—head and neck cancer	0.00195	0.00414	CcSEcCtD
Famotidine—Nausea—Hydroxyurea—head and neck cancer	0.00189	0.00402	CcSEcCtD
Famotidine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00189	0.00402	CcSEcCtD
Famotidine—Anaemia—Docetaxel—head and neck cancer	0.00188	0.00398	CcSEcCtD
Famotidine—Urticaria—Fluorouracil—head and neck cancer	0.00182	0.00387	CcSEcCtD
Famotidine—Syncope—Docetaxel—head and neck cancer	0.00182	0.00386	CcSEcCtD
Famotidine—Leukopenia—Docetaxel—head and neck cancer	0.00182	0.00386	CcSEcCtD
Famotidine—Body temperature increased—Fluorouracil—head and neck cancer	0.00181	0.00385	CcSEcCtD
Famotidine—Palpitations—Docetaxel—head and neck cancer	0.00179	0.00381	CcSEcCtD
Famotidine—Loss of consciousness—Docetaxel—head and neck cancer	0.00178	0.00379	CcSEcCtD
Famotidine—Cough—Docetaxel—head and neck cancer	0.00177	0.00376	CcSEcCtD
Famotidine—Convulsion—Docetaxel—head and neck cancer	0.00176	0.00373	CcSEcCtD
Famotidine—Arthralgia—Docetaxel—head and neck cancer	0.00173	0.00367	CcSEcCtD
Famotidine—Chest pain—Docetaxel—head and neck cancer	0.00173	0.00367	CcSEcCtD
Famotidine—Myalgia—Docetaxel—head and neck cancer	0.00173	0.00367	CcSEcCtD
Famotidine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00169	0.00359	CcSEcCtD
Famotidine—Dry mouth—Docetaxel—head and neck cancer	0.00169	0.00359	CcSEcCtD
Famotidine—Confusional state—Docetaxel—head and neck cancer	0.00167	0.00355	CcSEcCtD
Famotidine—Anaphylactic shock—Docetaxel—head and neck cancer	0.00166	0.00352	CcSEcCtD
Famotidine—Oedema—Docetaxel—head and neck cancer	0.00166	0.00352	CcSEcCtD
Famotidine—Infection—Docetaxel—head and neck cancer	0.00165	0.00349	CcSEcCtD
Famotidine—Shock—Docetaxel—head and neck cancer	0.00163	0.00346	CcSEcCtD
Famotidine—Pruritus—Fluorouracil—head and neck cancer	0.00162	0.00345	CcSEcCtD
Famotidine—Thrombocytopenia—Docetaxel—head and neck cancer	0.00162	0.00344	CcSEcCtD
Famotidine—Anorexia—Docetaxel—head and neck cancer	0.00158	0.00335	CcSEcCtD
Famotidine—Diarrhoea—Fluorouracil—head and neck cancer	0.00157	0.00333	CcSEcCtD
Famotidine—Dizziness—Fluorouracil—head and neck cancer	0.00152	0.00322	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00151	0.0032	CcSEcCtD
Famotidine—Insomnia—Docetaxel—head and neck cancer	0.0015	0.00318	CcSEcCtD
Famotidine—Paraesthesia—Docetaxel—head and neck cancer	0.00149	0.00316	CcSEcCtD
Famotidine—Somnolence—Docetaxel—head and neck cancer	0.00147	0.00313	CcSEcCtD
Famotidine—Vomiting—Fluorouracil—head and neck cancer	0.00146	0.0031	CcSEcCtD
Famotidine—Dyspepsia—Docetaxel—head and neck cancer	0.00146	0.0031	CcSEcCtD
Famotidine—Rash—Fluorouracil—head and neck cancer	0.00145	0.00307	CcSEcCtD
Famotidine—Dermatitis—Fluorouracil—head and neck cancer	0.00145	0.00307	CcSEcCtD
Famotidine—Decreased appetite—Docetaxel—head and neck cancer	0.00144	0.00306	CcSEcCtD
Famotidine—Headache—Fluorouracil—head and neck cancer	0.00144	0.00305	CcSEcCtD
Famotidine—Fatigue—Docetaxel—head and neck cancer	0.00143	0.00303	CcSEcCtD
Famotidine—Constipation—Docetaxel—head and neck cancer	0.00142	0.00301	CcSEcCtD
Famotidine—Pain—Docetaxel—head and neck cancer	0.00142	0.00301	CcSEcCtD
Famotidine—Feeling abnormal—Docetaxel—head and neck cancer	0.00136	0.0029	CcSEcCtD
Famotidine—Nausea—Fluorouracil—head and neck cancer	0.00136	0.00289	CcSEcCtD
Famotidine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00135	0.00288	CcSEcCtD
Famotidine—Abdominal pain—Docetaxel—head and neck cancer	0.00131	0.00278	CcSEcCtD
Famotidine—Body temperature increased—Docetaxel—head and neck cancer	0.00131	0.00278	CcSEcCtD
Famotidine—Hypersensitivity—Docetaxel—head and neck cancer	0.00122	0.00259	CcSEcCtD
Famotidine—Asthenia—Docetaxel—head and neck cancer	0.00119	0.00252	CcSEcCtD
Famotidine—Pruritus—Docetaxel—head and neck cancer	0.00117	0.00249	CcSEcCtD
Famotidine—Diarrhoea—Docetaxel—head and neck cancer	0.00113	0.00241	CcSEcCtD
Famotidine—Dizziness—Docetaxel—head and neck cancer	0.0011	0.00233	CcSEcCtD
Famotidine—Vomiting—Docetaxel—head and neck cancer	0.00105	0.00224	CcSEcCtD
Famotidine—Rash—Docetaxel—head and neck cancer	0.00104	0.00222	CcSEcCtD
Famotidine—Dermatitis—Docetaxel—head and neck cancer	0.00104	0.00222	CcSEcCtD
Famotidine—Headache—Docetaxel—head and neck cancer	0.00104	0.0022	CcSEcCtD
Famotidine—Nausea—Docetaxel—head and neck cancer	0.000984	0.00209	CcSEcCtD
